Gainers
CytoMed Therapeutics Limited (NASDAQ: GDTC) shares climbed 129.5% to $8.01 after gaining 9% on Monday.
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) gained 58.2% to $0.32 after the company issued a business update following favorable comments from US and EU regulatory meetings.
SOS Limited (NYSE: SOS) climbed 49.2% to $8.52.
Better Therapeutics, Inc. (NASDAQ: BTTX) shares climbed 42.2% to $1.2805 after the FDA approved the company's AspyreRx (formerly BT-001), a prescription-only digital treatment to provide cognitive behavioral therapy to adult patients with type 2 diabetes.
Taoping Inc. (NASDAQ: TAOP) gained 34.4% to $0.7099. Taoping posted 1H contract revenue of $14.65 million, up 95% year over year.
TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares climbed 29.6% to $0.57.
Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) rose 29.4% to $5.06 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $50 to $55.
Vivakor, Inc. (NASDAQ: VIVK) gained 21.6% to $1.29.
AgeX Therapeutics, Inc. (NYSE: AGE) rose 18.4% to $0.90.
The9 Limited (NASDAQ: NCTY) gained 18.2% to $1.1299.
Nuvve Holding Corp. (NASDAQ: NVVE) climbed 16.5% to $0.7927. Nuvve introduced artificial intelligence into its GIVe software platform via integration into the fleetbox charge management app.
Advent Technologies Holdings, Inc. (NASDAQ: ADN) gained 16.7% to $0.8980.
Greenidge Generation Holdings Inc. (NASDAQ: GREE) rose 15.4% to $7.55.
Virios Therapeutics, Inc. (NASDAQ: VIRI) rose 14.4% to $1.74.
Hesai Group (NASDAQ: HSAI) gained 14.4% to $12.34.
WD-40 Company (NASDAQ: WDFC) jumped 11.8% to $216.70 after the company reported third quarter results that topped expectations.
T2 Biosystems, Inc. (NASDAQ: TTOO) gained 10.7% to $0.1749 after jumping ...
Related tickers: SYTA, AGE, JUPW, GDTC, TTCF, ADCT, TTOO, NVVE, CENX, DERM, VIRI, NCTY, ETSY, VRDN, VOXX, ZG, AIRS, VRSN, ABOS, BTTX, WDFC, IOVA, TCBP, NWL, AREB, HSAI, ADN, ADIL, CARM, MOB, ELOX, DSS, TAOP, BRTX, UGRO, BYRN, GREE, CRKN, VIVK, SOS, SLRX.
Read Full Article